Effect of pentoxifylline on P-glycoprotein mediated vincristine resistance of L1210 mouse leukemic cell line
- 1. Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences, 83334 Bratislava (Slovak Republic)
- 2. Institute for Heart Research, Slovak Academy of Sciences, Bratislava (Slovak Republic)
Description
Effect of pentoxifylline (PTX) on vincristine (VCR) resistance of multidrug resistant L1210/VCR mouse leukemic cell line was studied. Reversal effect of PTX (in concentration 50-150 mg dm-3) on vincristine resistance, i.e. potentiation of vincristine cytotoxicity on L1210/VCR cells by PTX was found. PTX alone in the above concentration did not exert any significant effect on sensitive or resistant cell lines in the absence of vincristine. Resistance of L1210/VCR cell line was found previously to be accompanied with overexpression of drug transporting P-glycoprotein. Indeed, lower level of 3H-vincristine accumulation by resistant L1210/VCR cell line in comparison with sensitive L1210 cell line was observed. Accumulation of 3H-vincristine by L1210/VCR cell line was significantly increased in the presence of PTX. PTX in the same condition did not exert any considerable effect on accumulation of 3H-vincristine by nonresistant L1210 cells. Observable morphological damage was observed in 1210/VCR cells cultivated in medium containing vincristine (0.2 mg dm-3) and pentoxifylline (100 mg dm-3) in comparison with the non-damaged cells in the presence of vincristine or pentoxifylline alone. The results obtained indicate that pentoxifylline may be considered as a reversal agent in multidrug resistance. (author)
Additional details
Publishing Information
- Journal Title
- Neoplasma
- Journal Volume
- 41
- Journal Issue
- 5
- Journal Page Range
- p. 297-303
- ISSN
- 0028-2685
INIS
- Country of Publication
- Slovakia
- Country of Input or Organization
- Slovakia
- INIS RN
- 29060785
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Numerical Data
- Descriptors DEI
- CELL CULTURES; CHEMOTHERAPY; EXPERIMENTAL DATA; HEMATOLOGY; LABELLED COMPOUNDS; LABELLING; LEUKEMIA; MORPHOLOGY; NUCLEAR MEDICINE; ONCOVIN; RADIONUCLIDE KINETICS; TRACER TECHNIQUES; TRITIUM COMPOUNDS; UPTAKE
- Descriptors DEC
- ALKALOIDS; ANTIMITOTIC DRUGS; DATA; DISEASES; DRUGS; HYDROGEN COMPOUNDS; IMMUNE SYSTEM DISEASES; INFORMATION; ISOTOPE APPLICATIONS; KINETICS; MEDICINE; NEOPLASMS; NUMERICAL DATA; ORGANIC COMPOUNDS; THERAPY
Optional Information
- Contract/Grant/Project number
- SGAS-2/57/93
- Notes
- 6 figs., 22 refs.